| 2024-06-03 | Sale | Janux Therapeutics, Inc. JANX | Acting Chief Financial Officer | 822,721 1.5801% | $54.75 | $45.04M | -22.92% | |
| 2023-11-13 | Janux Therapeutics, Inc. JANX | Acting Chief Financial Officer | 849,854 1.538% | $5.87 | $4.99M | +430.86% | ||
| 2021-06-15 | Janux Therapeutics, Inc. JANX | Acting Chief Financial Officer | 629,411 5.7397% | $17.00 | $10.7M | +1.61% |